Literature DB >> 27417133

Tumor lysis syndrome in anti-androgen-treated metastatic prostate cancer.

Sandra Mazzoni1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27417133     DOI： 10.1007/s11255-016-1369-x

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


× No keyword cloud information.
  7 in total

1.  Fatal acute tumor lysis syndrome, hepatic encephalopathy and flare phenomenon following combined androgen blockade.

Authors:  Tawee Tanvetyanon; Abdul M Choudhury
Journal:  J Urol       Date:  2004-04       Impact factor: 7.450

2.  Acute tumor lysis syndrome - a rare complication in the treatment of solid tumors.

Authors:  Bertrand Coiffier
Journal:  Onkologie       Date:  2010-09-06

Review 3.  Tumor lysis syndrome: new challenges and recent advances.

Authors:  F Perry Wilson; Jeffrey S Berns
Journal:  Adv Chronic Kidney Dis       Date:  2014-01       Impact factor: 3.620

4.  Tumor lysis syndrome in a patient with metastatic, androgen independent prostate cancer.

Authors:  Jonathan L Wright; Daniel W Lin; Puneet Dewan; R Bruce Montgomery
Journal:  Int J Urol       Date:  2005-11       Impact factor: 3.369

Review 5.  Tumour lysis syndrome: new therapeutic strategies and classification.

Authors:  Mitchell S Cairo; Michael Bishop
Journal:  Br J Haematol       Date:  2004-10       Impact factor: 6.998

Review 6.  Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies.

Authors:  Ali McBride; Peter Westervelt
Journal:  J Hematol Oncol       Date:  2012-12-13       Impact factor: 17.388

Review 7.  Tumor Lysis Syndrome in Solid Tumors: An up to Date Review of the Literature.

Authors:  Aibek E Mirrakhimov; Alaa M Ali; Maliha Khan; Aram Barbaryan
Journal:  Rare Tumors       Date:  2014-06-13
  7 in total
  3 in total

1.  Spontaneous tumor lysis syndrome in a patient with metastatic prostate cancer.

Authors:  Naomi Serling-Boyd; Zoe Quandt; Nazima Allaudeen
Journal:  Mol Clin Oncol       Date:  2017-03-08

2.  Tumor lysis syndrome following cabazitaxel administration for metastatic castration-resistant prostate cancer: A case report.

Authors:  Masashi Oshima; Shozaburou Mayumi; Kai Yazaki; Yuuki Nakamura; Tsuzumi Konishi; Kimitoshi Saito; Satoshi Washino; Tomoaki Miyagawa
Journal:  IJU Case Rep       Date:  2019-04-15

Review 3.  Intricate Interplay of Entwined Metabolic and Inflammatory Life-threatening Processes in Tumor Lysis Syndrome Complicating Prostate Cancer: A Systematic Review with a Single Institution Experience.

Authors:  Dawood Findakly; Jue Wang
Journal:  Cureus       Date:  2020-03-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.